Seeing Is Believing
VERA is currently covered by 6 analysts with an average price target of $48.43. This is a potential upside of $10.61 (28.05%) from yesterday's end of day stock price of $37.82.
Vera Therapeutics's activity chart (see below) currently has 7 price targets and 28 ratings on display. The stock rating distribution of VERA is 86.36% BUY and 13.64% HOLD.
Analysts average stock forecasts to be materialized ratio is 86.35% with an average time for these price targets to be met of 166 days.
Highest price target for VERA is $68, Lowest price target is $21, average price target is $48.43.
Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 13-Aug-2024. First documented stock forecast 08-Jun-2021.
Currently out of the existing stock ratings of VERA, 19 are a BUY (86.36%), 3 are a HOLD (13.64%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
62
$24.18 (63.93%)
65
18 days ago
5/7 (71.43%)
$24.05 (63.37%)
271
Buy
68
$30.18 (79.80%)
37
3 months 21 days ago
2/3 (66.67%)
$26.68 (64.57%)
23
Hold
21
$-16.82 (-44.47%)
16
7 months 5 days ago
4/5 (80%)
$-9.18 (-30.42%)
182
Buy
25
$-12.82 (-33.90%)
25
8 months 4 days ago
7/7 (100%)
$9.07 (56.94%)
218
Buy
20
$-17.82 (-47.12%)
30
1 years 4 months 12 days ago
3/3 (100%)
$13.48 (206.75%)
252
What is VERA (Vera Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on VERA (Vera Therapeutics) with a proven track record?
Which analyst has the current lower performing score on VERA (Vera Therapeutics) with a proven track record?
Which analyst has the most public recommendations on VERA (Vera Therapeutics)?
Which analyst is the currently most bullish on VERA (Vera Therapeutics)?
Which analyst is the currently most reserved on VERA (Vera Therapeutics)?